Skip to content

Effect of Root Canal Treatment (Versus no Treatment) for Patients With Tooth Infections and Toothaches

Effect on Initial Endodontic Treatment on Postoperative Pain in Symptomatic Teeth With Pulpal Necrosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01870973
Enrollment
108
Registered
2013-06-06
Start date
2013-03-31
Completion date
2014-06-30
Last updated
2015-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

postoperative pain, root canal treatment

Brief summary

The purpose of this study is to evaluate patients with emergency pain and a sore (infected) tooth to determine if immediate root canal therapy is better at reducing pain, when compared to initial treatment with antibiotic and pain medication followed by root canal therapy. Each participant will be randomly assigned a number, which will determine if they will receive initial endodontic treatment that day or at a later date. Each participant will receive an anesthetic injection, pain medication and a prescription for an antibiotic. They will be asked to keep a diary to record their pain level after the injection and their pain levels and the amount and type of pain medication taken each day for the next 5 days. Participants who did not receive root canal therapy at the initial appointment will receive it after the 5 day postoperative period. The pain levels and medication use will be compared between the treatment and nontreatment groups.

Interventions

PROCEDUREroot canal treatment, anesthesia, pain medications, and antibiotic

Root canal treatment is the intervention (no initial treatment versus initial treatment). We are not studying a drug or device.

PROCEDUREno root canal treatment, anesthesia, pain medications, and antibiotic

Sponsors

Ohio State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * in good health (ASA classification I or II) * able to give informed consent * infected tooth with toothache (symptomatic tooth with pulpal necrosis)

Exclusion criteria

* allergy to ibuprofen, acetaminophen or codeine * history of significant medical problems (ASA classification III or greater) * angioedema or bronchospastic reactivity to aspirin or other NSAIDs * pregnant or lactating * inability to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Percent of Patients With Success as Defined by no or Mild Pain as Analyzed on a VAS Scale and no Narcotic Useeach day for 5 dayspain measurement as assessed on a visual analog scale and pain medication usage definition of success = no or mild pain as analyzed on VAS scale and no narcotic use; analyzed by logistic regression VAS scale is 0 to 170 mm with the higher numbers indicating more pain and less success.

Countries

United States

Participant flow

Participants by arm

ArmCount
Root Canal Treatment
root canal treatment, anesthesia with 2% lidocaine with 1:100,000 epinephrine, pain medication (1000 mg acetaminophen and 600 mg ibuprofen every 6 hours)five day supply, antibiotic (500 mg penicillin, if allergic 300 mg clindamycin) root canal treatment: Root canal treatment is the intervention (no initial treatment versus initial treatment). We are not studying a drug or device.
46
no Root Canal Treatment
no root canal treatment, anesthesia with 2% lidocaine with 1:100,000 epinephrine, pain medication (1000 mg acetaminophen and 600 mg ibuprofen every 6 hours)five day supply, antibiotic (500 mg penicillin if allergic 300 mg clindamycin) no root canal treatment
49
Total95

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up103

Baseline characteristics

CharacteristicRoot Canal Treatmentno Root Canal TreatmentTotal
Age, Continuous36.3 years
STANDARD_DEVIATION 12.1
39.1 years
STANDARD_DEVIATION 16.1
37.7 years
STANDARD_DEVIATION 14.1
Region of Enrollment
United States
46 participants49 participants95 participants
Sex: Female, Male
Female
20 Participants25 Participants45 Participants
Sex: Female, Male
Male
26 Participants24 Participants50 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 560 / 52
serious
Total, serious adverse events
0 / 560 / 52

Outcome results

Primary

Percent of Patients With Success as Defined by no or Mild Pain as Analyzed on a VAS Scale and no Narcotic Use

pain measurement as assessed on a visual analog scale and pain medication usage definition of success = no or mild pain as analyzed on VAS scale and no narcotic use; analyzed by logistic regression VAS scale is 0 to 170 mm with the higher numbers indicating more pain and less success.

Time frame: each day for 5 days

ArmMeasureValue (NUMBER)
Root Canal TreatmentPercent of Patients With Success as Defined by no or Mild Pain as Analyzed on a VAS Scale and no Narcotic Use52 percentage of participants
no Root Canal TreatmentPercent of Patients With Success as Defined by no or Mild Pain as Analyzed on a VAS Scale and no Narcotic Use43 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026